EPRX
Price
$3.94
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
139.14M
62 days until earnings call
ETNB
Price
$10.25
Change
+$0.29 (+2.91%)
Updated
Jun 6 closing price
Capitalization
1.45B
61 days until earnings call
Interact to see
Advertisement

EPRX vs ETNB

Header iconEPRX vs ETNB Comparison
Open Charts EPRX vs ETNBBanner chart's image
Eupraxia Pharmaceuticals
Price$3.94
Change-$0.00 (-0.00%)
Volume$11K
Capitalization139.14M
89bio
Price$10.25
Change+$0.29 (+2.91%)
Volume$1.58M
Capitalization1.45B
EPRX vs ETNB Comparison Chart
Loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. ETNB commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a Hold and ETNB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (EPRX: $3.94 vs. ETNB: $10.25)
Brand notoriety: EPRX and ETNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 79% vs. ETNB: 81%
Market capitalization -- EPRX: $139.14M vs. ETNB: $1.45B
EPRX [@Biotechnology] is valued at $139.14M. ETNB’s [@Biotechnology] market capitalization is $1.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileETNB’s FA Score has 1 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • ETNB’s FA Score: 1 green, 4 red.
According to our system of comparison, ETNB is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 3 TA indicator(s) are bullish while ETNB’s TA Score has 6 bullish TA indicator(s).

  • EPRX’s TA Score: 3 bullish, 5 bearish.
  • ETNB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ETNB is a better buy in the short-term than EPRX.

Price Growth

EPRX (@Biotechnology) experienced а +1.55% price change this week, while ETNB (@Biotechnology) price change was +4.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

EPRX is expected to report earnings on Aug 08, 2025.

ETNB is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($1.45B) has a higher market cap than EPRX($139M). ETNB YTD gains are higher at: 31.074 vs. EPRX (24.290). EPRX has higher annual earnings (EBITDA): -25.89M vs. ETNB (-380.21M). ETNB has more cash in the bank: 639M vs. EPRX (27.5M). EPRX has less debt than ETNB: EPRX (52.8K) vs ETNB (37.6M). EPRX (0) and ETNB (0) have equivalent revenues.
EPRXETNBEPRX / ETNB
Capitalization139M1.45B10%
EBITDA-25.89M-380.21M7%
Gain YTD24.29031.07478%
P/E RatioN/AN/A-
Revenue00-
Total Cash27.5M639M4%
Total Debt52.8K37.6M0%
TECHNICAL ANALYSIS
Technical Analysis
EPRXETNB
RSI
ODDS (%)
Bearish Trend 5 days ago
69%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
40%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AHSAX18.50N/A
N/A
Alger Health Sciences A
TOLLX16.81N/A
N/A
DWS RREEF Global Infrastructure A
AUUAX22.55N/A
N/A
AB Select US Equity A
JHQRX32.75N/A
N/A
JPMorgan Hedged Equity R6
CBHMX8.72N/A
N/A
Victory Market Neutral Income Member

EPRX and

Correlation & Price change

A.I.dvisor tells us that EPRX and CCCC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPRX and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
N/A
CCCC - EPRX
29%
Poorly correlated
+17.69%
ETNB - EPRX
28%
Poorly correlated
+2.91%
ACAD - EPRX
28%
Poorly correlated
+3.00%
FDMT - EPRX
26%
Poorly correlated
+11.25%
ALEC - EPRX
26%
Poorly correlated
+5.67%
More

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+2.91%
AKRO - ETNB
59%
Loosely correlated
+0.63%
IDYA - ETNB
54%
Loosely correlated
+2.99%
CRNX - ETNB
52%
Loosely correlated
+2.13%
COGT - ETNB
51%
Loosely correlated
+13.52%
DNLI - ETNB
51%
Loosely correlated
+3.38%
More